The expression of IL-13Rα2 was observed to be significantly higher in the metastatic prostate cancer cell lines DU145 and PC-3 than in either the non-cancerous prostate cell line PNT2 or the non-metastatic prostate cancer cell line LNCaP. Here, IL13RA2 is linked to prostate carcinoma.